Oxford's R21/Matrix-M malaria vaccine has been proven highly effective. It has been trialled in Burkina Faso, Kenya, Mali and Tanzania.

The WHO has recommended the vaccine for use in countries around the world. Agreements are in place to deliver hundreds of millions of doses.

Malaria kills hundreds of thousands every year, mostly young children. R21/Matrix-M could reduce that great loss, alongside existing malaria controls.